Mérieux Equity Partners

Menu

bandeau news

We’re on the move, you stay in the news

Our news

2022-10-14

Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
2022-09-27

Dr Jeanne Bolger, the new Chair of AstriVax
2022-08-30

IPEM 2022 - Cannes

Mérieux Equity Partners will attend IPEM 2022 event, on September 20,21 and 22nd at the festival palaces (Cannes)
Meet our GBO and VC teams at Level...
2022-08-25

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform
2022-08-22

Merieux Equity Partners announces the first two exits of Mérieux Participations 3
2022-07-19

Mérieux Equity Partners invests in Janvier Labs
2022-07-18

SOS Uganda Initiative
2022-06-27

MRM Health starts clinical trial Pouchitis

MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis
2022-06-06

MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis